Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Parallel, Randomized, Placebo Controlled Trial to Evaluate Onset of Action of Loratadine and Fexofenadine in Subjects With Seasonal Allergic Rhinitis in a Pollen Challenge Chamber

NCT01469234 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01469234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01469234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Parallel, Randomized, Placebo Controlled Trial to Evaluate Onset of Action of Loratadine and Fexofenadine in Subjects With Seasonal Allergic Rhinitis in a Pollen Challenge Chamber
Lead sponsor
Bayer
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2011
Completion date
November 30, 2011
Enrollment
255 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rhinitis